![Malcolm L. McConville](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malcolm L.
McConville worked as a Development Director at AmpliPhi Biosciences Corp.
and as a Development Manager at Biocontrol Ltd. (United Kingdom).
He holds a doctorate degree from The University of Reading and an undergraduate degree from the University of Cardiff.
| Sociétés | Poste | Fin |
|---|---|---|
Biocontrol Ltd. (United Kingdom)
 Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Develops chemical treatment to cure antibiotic resistant infections | Corporate Officer/Principal | - |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
 University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biocontrol Ltd. (United Kingdom)
Biocontrol Ltd. (United Kingdom) BiotechnologyHealth Technology Develops chemical treatment to cure antibiotic resistant infections | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
